SHR-A2102 ; Adebrelimab injection

DRUG2 trials

Sponsors

Shanghai Hengrui Pharmaceutical Co., Ltd., Henan Cancer Hospital

Conditions

Advanced Solid TumorsTNBC - Triple-Negative Breast Cancer

Phase 1

A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors

RecruitingNCT06417554

Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2024-05-13End: 2027-07-31Target: 80Updated: 2024-12-31

Phase 2

SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer

Not yet recruitingNCT06819319

Henan Cancer HospitalTNBC - Triple-Negative Breast Cancer

Start: 2025-06-23End: 2030-12-31Target: 52Updated: 2025-06-23